Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 117

1.

BMP-9-induced muscle heterotopic ossification requires changes to the skeletal muscle microenvironment.

Leblanc E, Trensz F, Haroun S, Drouin G, Bergeron E, Penton CM, Montanaro F, Roux S, Faucheux N, Grenier G.

J Bone Miner Res. 2011 Jun;26(6):1166-77. doi: 10.1002/jbmr.311.

PMID:
21611960
2.

Low dose fibroblast growth factor-2 (FGF-2) enhances bone morphogenetic protein-2 (BMP-2)-induced ectopic bone formation in mice.

Nakamura Y, Tensho K, Nakaya H, Nawata M, Okabe T, Wakitani S.

Bone. 2005 Mar;36(3):399-407. Erratum in: Bone. 2006 Jul;39(1):222. Bone. 2007 Jan;40(1):244-5.

PMID:
15777655
3.

Heterotopic ossification of degenerating rat skeletal muscle induced by adenovirus-mediated transfer of bone morphogenetic protein-2 gene.

Gonda K, Nakaoka T, Yoshimura K, Otawara-Hamamoto Y, Harrii K.

J Bone Miner Res. 2000 Jun;15(6):1056-65.

PMID:
10841174
4.

Inductive properties of recombinant human BMP-2 produced in a bacterial expression system.

Kübler NR, Reuther JF, Faller G, Kirchner T, Ruppert R, Sebald W.

Int J Oral Maxillofac Surg. 1998 Aug;27(4):305-9.

PMID:
9698181
5.

Enhancement of crude bone morphogenetic protein-induced new bone formation and normalization of endochondral ossification by bisphosphonate treatment in osteoprotegerin-deficient mice.

Tabuchi M, Miyazawa K, Kimura M, Maeda H, Kawai T, Kameyama Y, Goto S.

Calcif Tissue Int. 2005 Oct;77(4):239-49. Epub 2005 Sep 28.

PMID:
16193235
6.

RNA interference for noggin enhances the biological activity of bone morphogenetic proteins in vivo and in vitro.

Takayama K, Suzuki A, Manaka T, Taguchi S, Hashimoto Y, Imai Y, Wakitani S, Takaoka K.

J Bone Miner Metab. 2009;27(4):402-11. doi: 10.1007/s00774-009-0054-x. Epub 2009 Feb 28.

PMID:
19252814
7.

Fibrodysplasia ossificans progressiva-related activated activin-like kinase signaling enhances osteoclast formation during heterotopic ossification in muscle tissues.

Yano M, Kawao N, Okumoto K, Tamura Y, Okada K, Kaji H.

J Biol Chem. 2014 Jun 13;289(24):16966-77. doi: 10.1074/jbc.M113.526038. Epub 2014 May 5.

PMID:
24798338
8.

The inhibition effects of insulin on BMP2-induced muscle heterotopic ossification.

Zhang J, Zhao Y, Hou X, Chen B, Xiao Z, Han J, Shi C, Liu J, Miao Q, Dai J.

Biomaterials. 2014 Nov;35(34):9322-31. doi: 10.1016/j.biomaterials.2014.07.056. Epub 2014 Aug 15.

PMID:
25132600
9.

Regulation of BMP-induced ectopic bone formation by Ahsg.

Rittenberg B, Partridge E, Baker G, Clokie C, Zohar R, Dennis JW, Tenenbaum HC.

J Orthop Res. 2005 May;23(3):653-62.

PMID:
15885488
10.

BMP-9 regulates the osteoblastic differentiation and calcification of vascular smooth muscle cells through an ALK1 mediated pathway.

Zhu D, Mackenzie NC, Shanahan CM, Shroff RC, Farquharson C, MacRae VE.

J Cell Mol Med. 2015 Jan;19(1):165-74. doi: 10.1111/jcmm.12373. Epub 2014 Oct 9.

PMID:
25297851
11.

Osteoprogenitor cells within skeletal muscle.

Bosch P, Musgrave DS, Lee JY, Cummins J, Shuler T, Ghivizzani TC, Evans T, Robbins TD, Huard.

J Orthop Res. 2000 Nov;18(6):933-44.

PMID:
11192254
12.

Bone morphogenetic protein-2 decorated silk fibroin films induce osteogenic differentiation of human bone marrow stromal cells.

Karageorgiou V, Meinel L, Hofmann S, Malhotra A, Volloch V, Kaplan D.

J Biomed Mater Res A. 2004 Dec 1;71(3):528-37.

PMID:
15478212
13.

Deletion mutants of BMP folding variants act as BMP antagonists and are efficient inhibitors for heterotopic ossification.

Weber FE, Schmökel H, Oelgeschläger M, Nickel J, Maly FE, Hortschansky P, Grätz KW.

J Bone Miner Res. 2003 Dec;18(12):2142-51.

PMID:
14672349
14.

Influence of Bone and Muscle Injuries on the Osteogenic Potential of Muscle Progenitors: Contribution of Tissue Environment to Heterotopic Ossification.

Molligan J, Mitchell R, Schon L, Achilefu S, Zahoor T, Cho Y, Loube J, Zhang Z.

Stem Cells Transl Med. 2016 Jun;5(6):745-53. doi: 10.5966/sctm.2015-0082. Epub 2016 Apr 25.

PMID:
27112178
15.

[Clinical aspects, differential diagnosis and histogenesis of heterotopic ossification].

Bosse A.

Veroff Pathol. 1997;146:1-168. German.

PMID:
9123963
16.

Retroviral delivery of Noggin inhibits the formation of heterotopic ossification induced by BMP-4, demineralized bone matrix, and trauma in an animal model.

Hannallah D, Peng H, Young B, Usas A, Gearhart B, Huard J.

J Bone Joint Surg Am. 2004 Jan;86-A(1):80-91.

PMID:
14711949
17.

A novel mouse model of trauma induced heterotopic ossification.

Liu X, Kang H, Shahnazari M, Kim H, Wang L, Larm O, Adolfsson L, Nissenson R, Halloran B.

J Orthop Res. 2014 Feb;32(2):183-8. doi: 10.1002/jor.22500. Epub 2013 Oct 17.

PMID:
24136593
18.

Possible involvement of bone morphogenetic protein 2 in heterotopic ossification in metastatic lesion from urothelial carcinoma of bladder.

Komai Y, Morimoto S, Saito K, Urushibara M, Sakai K, Ikeda S.

Int J Urol. 2006 Aug;13(8):1126-8.

PMID:
16903944
19.

Interaction between soluble type I receptor for bone morphogenetic protein and bone morphogenetic protein-4.

Natsume T, Tomita S, Iemura S, Kinto N, Yamaguchi A, Ueno N.

J Biol Chem. 1997 Apr 25;272(17):11535-40.

PMID:
9111068
20.

Botulinum Toxin-induced Muscle Paralysis Inhibits Heterotopic Bone Formation.

Ausk BJ, Gross TS, Bain SD.

Clin Orthop Relat Res. 2015 Sep;473(9):2825-30. doi: 10.1007/s11999-015-4271-4.

PMID:
25804882

Supplemental Content

Support Center